StockData
Curaleaf Holdings, Inc. logo

Curaleaf Holdings, Inc. (CURLF) stock

CURLFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/30
$7.63−0.20 (-2.55%)

Close on Oct 19, 2026Market cap $2.07BP/E –Yield –

Curaleaf operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

For fiscal 2025 it was $25.45M, up 2.9% from the year before. The highest annual figure on record is $72.44M in fiscal 2020.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$25.45M+2.9%
FY2024Dec 31, 2024$24.74M-42.3%
FY2023Dec 31, 2023$42.88M-34.0%
FY2022Dec 31, 2022$64.99M+11.0%
FY2021Dec 31, 2021$58.57M-19.1%
FY2020Dec 31, 2020$72.44M–
FY2019Dec 31, 2019-$27.72M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$4.22M–
Q2 FY2025Jun 30, 2025$6.25M–

More Curaleaf figures

See a number that looks wrong?